UK Startup's Astral Fusion Reactor Revolutionizes Nuclear Medicine for Cancer Treatment

UK startup Astral Systems has developed a Multi-State Fusion (MSF) Reactor, a first-of-its-kind technology that can produce medical isotopes used in cancer diagnosis and treatment. The reactor has the potential to revolutionize targeted cancer therapy by effectively killing cancer cells during radiotherapy. Astral Systems aims to leverage nuclear medicine to save lives and directly treat tumors and cancerous cells at their source.